Form D · Other Health Care
Ureteral Stent Co
Cleveland, OH · CIK 0001807112
Offering snapshot reported Mar 23, 2020 · SEC filing
- Reported sold
- $1.24M Offering amount: $2M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $21.5K Reported outside-investor minimum
- First sale
- Mar 3, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 23, 2020 | Initial | $1,239,310 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-363464
Includes the aggregate value of Series A Preferred stock issued upon conversion of outstanding convertible promissory notes issued to-date, including accrued interest, and shares of Series A Preferred Stock purchased for cash
Conversion of convertible promissory notes in exchange for Series A Preferred Stock
Source: Form D, filed Mar 23, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Attias | Executive |
| Michael Bunker | Director, Executive |
| Rafid Fadul | Director |
| Lee Ponsky | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2191 Murray Hill Road
Cleveland, OH, 44106
Cleveland, OH, 44106